A new study from the USC Leonard D. Schaeffer Center for Health Policy and Economics confirms that dementia diagnoses increased across the United States after Medicare Advantage (MA) began calculating plan payments to account for Alzheimer’s disease and related dementias.

The change gives MA plans financial incentive to improve dementia detection, which has sparked a discussion regarding the positive and negative implications for Medicare, MA, doctors and their patients.

The study was published in Jama Network Open.

To read the full story, click here.